An Iongen Therapeutics Co. Ltd. patent reports transient receptor potential vanilloid 3 (TRPV3) receptor antagonists that are potentially useful for the treatment of acne, diabetes, anxiety, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback